12
3 Page 3 of 19
45...19
Stigma generated and reinforced by healthcare practitioners results in humiliation, reduced access to care, and ultimately fuels the cycle of addiction for people with opioid and other substance use disorders. Stigmatizing perceptions related to opioid
Member: $0.00
Non-Member: $0.00
0.75 AAPA Category 1 CME credit
PAOS Extremities in the Carolinas 2022 Bundle offers up to 14 AAPA Category 1 CME credits and 5 AAPA Category 1 Self-Assessment CME credits including topics on orthobiologics, hand & wrist, ankle & midfoot, hip & knee, and more, all on demand. This is the perfect course for advanced knowledge on the diagnosis and management of many musculoskeletal conditions.
Member: $299.00
Non-Member: $449.00
19.00 AAPA Category 1 CME credit
From orthobiologics, hand & wrist, ankle & midfoot, hip & knee, and more, all on demand.
Member: $249.00
Non-Member: $399.00
14.00 AAPA Category 1 CME credit
This case-based self-assessment activity outlines evaluation and treatment of extremity injury, plus new clinical and technical skills to improve delivery of healthcare to patients with upper and/or lower extremity trauma. This CME expires September 30, 2024, 11:59 PM EDT.
Member: $149.00
Non-Member: $249.00
5.00 AAPA Category 1 Self-Assessment CME credit
This five-part podcast series aims to equip PAs and other clinicians with the education and tools to assist in providing patient-centered care in the early recognition, diagnosis, and management of patients presenting in the outpatient setting with sympt
Member: $0.00
Non-Member: $0.00
2.50 AAPA Category 1 CME credit
PAOS 2021 Bundle offers up to 23.75 AAPA Category 1 CME credits and 5 AAPA Category 1 Self-Assessment CME credits including topics on shoulders, knees, spine, infections, MRI interpretations, surgical techniques and more, all on demand. This is the perfect course for advanced knowledge on the diagnosis and management of many musculoskeletal conditions.
Member: $449.00
Non-Member: $599.00
28.75 AAPA Category 1 CME credit
From topics on shoulders, knees, spine, infections, MRI interpretations, surgical techniques and more, all on demand.
Member: $399.00
Non-Member: $549.00
23.75 AAPA Category 1 CME credit
This case-based self-assessment activity outlines evaluation and treatment of extremity injury, plus new clinical and technical skills to improve delivery of healthcare to patients with upper and/or lower extremity trauma.
Member: $149.00
Non-Member: $249.00
5.00 AAPA Category 1 Self-Assessment CME credit
In both infants and older adults, pneumococcal pneumonia continues to be a leading cause of death. The incidence of pneumonia and related mortality are highest in adults ≥65 years of age and patients with comorbidities. While young children also have increased risk of morbidity and mortality due to pneumonia, it is not to the same extent as seen in older adults. The most recent guidance for vaccination practices was provided by the Center for Disease Control’s (CDC) Advisory Committee on Immunization Practices (ACIP) in 2019. Since then, there have been several key changes in pneumococcal vaccination. These key updates include the approval of two pneumococcal vaccines in adults and new pediatric vaccination data. Clinicians treating those at risk of pneumococcal pneumonia and invasive pneumococcal disease (IPD) require increased education on the impact of pneumococcal pneumonia and IPD, the importance of serotypes in pneumococcal disease and IPD, and updated information on recent approvals and evidence.
Member: $0.00
Non-Member: $0.00
0.75 AAPA Category 1 CME credit
In both infants and older adults, pneumococcal pneumonia continues to be a leading cause of death. The incidence of pneumonia and related mortality are highest in adults ≥65 years of age and patients with comorbidities. While young children also have increased risk of morbidity and mortality due to pneumonia, it is not to the same extent as seen in older adults. The most recent guidance for vaccination practices was provided by the Center for Disease Control’s (CDC) Advisory Committee on Immunization Practices (ACIP) in 2019. Since then, there have been several key changes in pneumococcal vaccination. These key updates include the approval of two pneumococcal vaccines in adults and new pediatric vaccination data. Clinicians treating those at risk of pneumococcal pneumonia and invasive pneumococcal disease (IPD) require increased education on the impact of pneumococcal pneumonia and IPD, the importance of serotypes in pneumococcal disease and IPD, and updated information on recent approvals and evidence.
Member: $0.00
Non-Member: $0.00
0.75 AAPA Category 1 Self-Assessment CME credit
12
3 Page 3 of 19
45...19